Transaction positions Jaguar to advance the Laminar program and its differentiated approach to left atrial appendage closure for patients with non-valvular atrial fibrillation SANTA ROSA, Calif., Sept. 11, 2026 /PRNewswire/ — Jaguar LAA, Inc. (“Jaguar”), a privately held medical device…
